Crescent Capital BDC (CCAP) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Net investment income per share was $0.42 for Q1 2026, down from $0.45 in the prior quarter, primarily due to lower interest income and higher non-accruals.
Net asset value (NAV) per share declined to $18.27 from $19.10 quarter-over-quarter.
Net realized and unrealized losses on investments per share were ($0.84), compared to ($0.21) in the previous quarter.
Portfolio fair value at March 31, 2026 was approximately $1.56 billion, diversified across 192 companies and 18 industries, with 99.2% of debt investments at floating rates.
Management and incentive fees were permanently reduced, and Sun Life completed its acquisition of Crescent Capital, strengthening institutional alignment.
Financial highlights
Total investment income was $37.9 million in Q1 2026, down from $42.1 million year-over-year.
Net investment income was $15.5 million ($0.42 per share), with net realized and unrealized losses totaling $31.0 million.
Net assets were $674 million as of March 31, 2026, with total assets at $1.62 billion.
Net leverage ended at 1.32x, slightly above the target range, and debt-to-equity ratio increased to 1.36x.
Portfolio net interest margin was 6.1% for Q1 2026, with a weighted average cost of debt at 6.09%.
Outlook and guidance
Base management fee reduced from 1.25% to 1.00% and incentive fee from 17.5% to 15.0%, effective April 1, 2026.
Quarterly base dividend reset from $0.42 to $0.34 per share, with three special dividends of $0.03 per share each approved for 2026.
No Q1 supplemental dividend will be paid based on this quarter's NII.
Management expects general and administrative expenses to remain stable or decline as a percentage of assets during periods of asset growth.
Not expecting significant net portfolio growth in the near term; focus remains on portfolio rotation and selective deployment.
Latest events from Crescent Capital BDC
- Directors were elected through 2029 and Ernst & Young LLP was ratified as auditor for 2026.CCAP
AGM 202615 May 2026 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 20256 May 2026 - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 20256 Apr 2026 - Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing1 Apr 2026 - Virtual meeting to elect directors and ratify E&Y as auditor, with strong governance oversight.CCAP
Proxy filing1 Apr 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 202414 Jan 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025